Veteran biotech investor to steer IBC’s impact fund targeting early-stage therapies, diagnostics, and technologies for immune disorders.
Immune Boost Capital (IBC), the newly formed...
Veteran biotech investor to steer IBC’s impact fund targeting early-stage therapies, diagnostics, and technologies for immune disorders.
Immune Boost Capital (IBC), the newly formed...
Here is a short wherein Dr Sanjeev Agrawal answers the question from comment section where the person is facing Rheumatoid Arthritis and his Anti-CCP...
Recent Comments